Higher Exchanges
Higher Exchanges
Higher Exchanges is the number one independent cannabis investing show. Hosted by Jesse Redmond and Morgan Paxhia, the show features candid conversations with top CEOs, operators, and capital allocators shaping the future of cannabis. We break down complex cannabis markets into clear insights you can actually use. Higher Exchanges is powered by Flowhub and features original intro music by Chris Otchy.
Be sure to visit the podcast's website and support the creator: www.buzzsprout.com
Author
Higher Exchanges
Category
Podcast website
Latest episode
Nov 12, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Merger Mania 06.06.2024 57:49
It's merger mania week--or merger maybenia as Morgan called it--and this week's show is dedicated to the potential partnerships between GTI and Sam Adams and Cansortium and RIV Capital. We tackle GTI and SAM off the top with an overview of the proposed merger and discuss the timing and synergies. We debate the timing and wonder why now as we are just approaching potential federal reform...
Reality Doesn't Bite 30.05.2024 1:01:29
With Toby on holiday this week, Morgan and Jesse kick off this week's show by reviewing recent price action and contrasting it with reality. While falling share prices have eroded sentiment, there are positive developments. Ohio is beginning to turn on adult-use stores next month, and we analyze key dates, estimate the potential size of the adult-use market, and dig into MSO exposure in the...
Rescheduling Reaction and Earnings Review With CannaVestments 23.05.2024 1:16:47
Nick Gastevich, known as CannaVestments online, joined us this week. He is one of the most experienced cannabis investors and manages a family office that is active in the space. We discussed cannabis stock’s adverse reaction to the positive momentum on rescheduling and debated time frames for a final ruling. The heart of the conversation centers on first-quarter earnings, and we evaluated top-...
Political and Earnings Updates With Cresco CEO Charlie Bachtell 17.05.2024 58:59
Cresco CEO Charlie Bachtell joined us this week to discuss the proposed rule on Schedule III and the company's recent earnings results. Cresco is active in Washington, and Charlie shared his perspective on Schedule III’s next steps, timing, and impact on Cresco's business. We also dug into Cresco's progress. 2023 was the year of the core, and Charlie highlighted the tough decisions...
Cash Flow Is King With Verano’s George Archos 09.05.2024 1:00:51
Verano Co-Founder, Chairman, and CEO George Archos joined the show to discuss the company's recent quarter. The business is beginning to generate significant cash flow, and George shared how he expects revenue to grow and opportunities to use the financial flexibility. We also asked about optimizing Florida assets ahead of the potential adult-use transition and M&A strategy. The second h...
The DEA Agrees With Schedule III Starring Boris Jordan and Hirsh Jain 30.04.2024 1:09:38
Today, we heard the welcome news that the DEA is agreeing with the HHS recommendation to move cannabis from Schedule I to Schedule III. Boris Jordan, Executive Chairman of Curaleaf, joins at the top of the show to share his thoughts on the next steps in the process, the timing of a final ruling, potential risks along the way, implications for institutional interest, and the specific impact of 28...
Waiting on the World to Change 25.04.2024 1:07:00
It's a quieter time in cannabis, but this was a fun show. We started by reviewing the 4/20 holiday, focusing on the revenue lift and which categories performed best. Beverages were a top seller, and the guys debated the category's future and who will drive its growth. We debuted a new game called "buy or sell" that led to several fun debates on rescheduling probabilities, how...
The Waiting Is the Hardest Part 19.04.2024 1:19:10
The trichome trio is home from the Benzinga Cannabis Capital Conference in Florida and the show starts with their biggest takeaways from the event. The conversation evolves into a spirited discussion on where we stand on Schedule III. The guys debate the probability of landing on Schedule III and the time frame in which it may happen. The episode concludes by talking about the AGP sentiment surve...
The Catalyst Table Starring Hirsh Jain 11.04.2024 1:10:15
2024 is the year of potential cannabis catalysts and we had Hirsh Jain, Founder of Ananada Strategy join us to discuss a bevy of federal and state-level opportunities. Next week is 4/20, and one potential time that the DEA could respond to the HHS' Schedule III recommendation. The trio debates the probability of a response and the implications to short and long-term investors. On the state s...
Florida Update With AYR Wellness CEO David Goubert 04.04.2024 57:49
This week's show starts with a recap of adult use making the ballot in Florida and what it may mean to the industry. Morgan shares his perspective after recently visiting the Sunshine State. We cover the pros can cons of the mandatory vertical market and opportunities for smaller companies like Sunburn to expand if adult use succeeds. Toby gives his thoughts on how Florida will expand the TAM...
Cannabis Catalyst Update With Sammy J 29.03.2024 1:07:03
Jesse starts the show by sharing his experiences visiting LEEF Brands and Gold Flora. LEEF is a leading producer of concentrates in California and he went to see their 12,500-square-foot extraction facility in Northern California. Gold Flora is a top vertically integrated California company and Jesse shared his experience seeing their stores and cultivation facilities in San Jose. Sam Armenia, kn...
TerrAscend Q4 2023 Earnings Review with Jason Wild and Ziad Ghanem 21.03.2024 58:23
The show kicks off with Toby sharing his experience at the ROTH Conference this week in Dana Point, California. We discuss how institutions are beginning to look at cannabis, but it will take federal reform for most to spend more time and resources on due diligence. Jesse and Morgan also talk about things it takes to win in the difficult California market. TerrAscend Executive Chairman Jason Wild...
Ascend Q4 2023 Earnings Review with CEO John Hartmann 14.03.2024 1:01:41
We are deep in Q4 2023 earnings season and this week's show starts with Jesse, Morgan, and Toby sharing their biggest takeaways from the results so far. Jesse covers how margins are evolving, Morgan complements that with cash-flow conversion metrics, and Toby gives his perspective on the various 280E tax strategies we are seeing utilized. Ascend CEO John Hartmann joins 20 minutes into the ep...
Curaleaf Earnings Review with Boris Jordan and CannaVestments 08.03.2024 1:25:13
This week's show had an all-star cast to review recent earnings. CannaVestments shared his thoughts on the federal and state-level catalysts in 2024 and contrasted this against eroding investor sentiment. He also gave his perspective on the recent results from GTI, Verano, and Trulieve. Boris Jordan, Executive Chairman of Curaleaf, joined the show to review the company's Q4 2023 earning...
GTI, Trulieve, and Verano Q4 Earnings Reviews 02.03.2024 1:04:10
GTI, Trulieve, and Verano reported Q4 2023 earnings this week and the guys dig deep into the results. To discuss Verano, they are joined by the company's President Darren Weiss, CIO Aaron Miles, and CFO Brett Summerer. Plus, Morgan asks Grok about cannabis bear Mitch McConnell's retirement and what it means for the cannabis sector
Earnings Preview and Germany Review With Boris Jordan 23.02.2024 1:15:31
This week's show begins by discussing the Benzinga cannabis conference in Los Angeles. Morgan and Jesse left inspired by the strength of brands, the quality of products, and the lack of focus on politics. Boris Jordan, Executive Chairman of Curaleaf, joined to discuss the recent events in Germany. He shares how he sees the program evolving and the economic opportunity for Curaleaf. Earnings...
The Thesis Is in Tact Starring Sammy J 16.02.2024 1:01:37
Morgan's on the road, so Jesse and Toby start the show reviewing the recent pullback in cannabis stocks and the corresponding drop in sentiment. Toby also shares his experience at the Cannacord webinar and Jesse explains how the institutional investments in cannabis compare to more mature sectors. Sam Armenia, known as Sammy J on Twitter and VP of Corporate Development at C21 Investments, ...
Do Valuations Matter? 08.02.2024 1:03:15
Jesse, Toby, and Morgan begin the show by catching up on the latest cannabis-investing news. Sentiment around the timing of the DEA's response continues to improve and this is driving inflows into the US cannabis MSOS ETF. The group also covers the addition of Ascend to the MSOS portfolio. The bulk of the conversation is around the importance of valuations in the cannabis sector and which me...
The Improving Risk-Reward Equation for US Cannabis 02.02.2024 1:18:01
Jesse, Morgan, and Toby are back together to discuss the improving environment for US cannabis stocks. This is the fifth consecutive week of gains and broad US cannabis benchmarks are up over 50% this year. The boys analyze and appreciate the recent run in cannabis stocks and discuss how the space has evolved since the HHS announcement. They review the top performers AYR and Trulieve and those tha...
Appreciating the Good Times With Verano’s Darren Weiss and Aaron Miles 26.01.2024 1:09:59
This week's show starts with Jesse, Morgan, and Toby discussing the strong start to 2024. The group evaluates what's been driving the positive returns and inflows to the MSOS and MSOX ETFs. Verano President Darren Weiss and CIO Aaron Miles join 20 minutes into the episode. Darren and Aaron react to the contents of the HHS recommendation and also update us on the Boies lawsuit. We also d...
Reviewing the HHS Recommendation With Brady Cobb and Boris Jordan 16.01.2024 1:17:43
This week Jesse, Morgan, and Toby discussed the release of the HHS rescheduling recommendation. For the first half hour, Brady Cobb, Founder and CEO of Sunburn Cannabis, shares his perspective on the contents and timing of the release. He also adds his thoughts on the implications of 280E removal and how he thinks about it from an operator's perspective. Higher Exchanges is recorded live on...
Returning to Growth 12.01.2024 1:18:00
This week's show begins by talking about how Jesse is seeing increased interest in companies wanting to tell their stories ahead of a potential increase in the investor base. This is complemented by observations that the cannabis capex cycle may be improving. On the state level, new Illinois data shows the state had a strong year, which is contrasted against Tilray's earnings report and...
2024 Cannabis Investing Preview 04.01.2024 1:15:10
This week on Higher Exchanges the guys start by recapping the holiday break and how they were not surprised that we did not hear from the DEA. This transitions into a conversation about the "news" that the DEA is reviewing cannabis scheduling. While our listeners knew this, it was nice to see the uptick in attention by those following less closely. The heart of the episode is about what...
Recapping 2023's Top Cannabis Investing Stories 21.12.2023 1:03:52
This week Morgan and Jesse recap the top cannabis-investing stories from 2023. HHS announcing its recommendation for Schedule III was the consensus top pick, especially when paired with the Boies lawsuit. Other notable news includes Maryland launching adult-use sales, Ohio voting in favor of adult use, increased operational efficiencies, cannabis sales increasing while alcohol declines, and uplist...
Curaleaf Uplisting With Boris Jordan 15.12.2023 59:46
Toby is on vacation, so Jesse and Morgan kick off the show discussing recent performance and the latest Schedule III speculation. Jesse shares data on different portfolios he's tracking that may indicate what types of stocks will perform best in the event we get positive news from the DEA. Curaleaf Executive Chairman Boris Jordan joins halfway through to discuss the company's uplisting f...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.